ARGENT BIOPHARMA LIMITED — Director's Dealing 2012

Jul 16, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	Health Corporation Limited
ABN	30 116 800 269

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Grant Davey
Date of last notice	22 June 2012

Part 1 ‐ Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.	Elgra Consultancy Pty Ltd(Sole Director and Beneficiary)
Date of change	1. 12 July 20122. 16 July 2012
No. of securities held prior to change	12,500,000 Ordinary Shares
Class	1. Ordinary Shares2. Ordinary Shares
Number acquired	1. 350,0002. 150,000
Number disposed	Nil
Value/ConsiderationNote: If consideration is non‐cash, provide details andestimated valuation	1. $8,8602. $3,777.50

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Grant Davey12,500,000 Ordinary SharesElgra Consultancy Pty Ltd500,000 Ordinary Shares
Nature of changeExample: on‐market trade, off‐market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,participation in buy‐back	On Market Trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 – Closed Period

Part 3 – Closed Period
Were the interests in the securities orcontractsdetailedabovetradedduring a closed period where priorwritten clearance was required?	No
If so, was prior written clearanceprovided to allow the trade toproceed during thisperiod?	N/A
Ifpriorwrittenclearancewasprovided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002